Caprelsa (vandetanib) - Esteve
zeteletinib (BOS-172738) - Boston Pharma
soxataltinib (SY-5007) - Shouyao Holdings
Cabometyx (cabozantinib tablet) - Exelixis
Gavreto (pralsetinib) - Rigel Pharmaceuticals
Retevmo (selpercatinib) - Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/42525389
 
Azeem Izhar; Danica M Vodopivec; Hameeda Arif Arain; Herbert Chen; Rachael Caretti
 
Jul 30, 2026
 
Prev Next